BioTrack, Yonjin et al Tackle Unmet Medical Needs
09 Sep 2025
US$ 20.00
BioTrack Capital and Yonjin Venture LLC were party to the US$44 m series A funding round of Rapafusyn ......
Related Publications
Subscribers’ Weekly for the week ending 12 Sep 2025...
Listen to Australia/New Zealand Funds (Subscribers' Weekly 12 Sep 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.